• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human UPF0606 protein KIAA1549 (KIAA1549), Truncated

ACP05771

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP05771 Target NameKIAA1549
Target SynonymsKIAA1549; UPF0606 protein KIAA1549FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9HCM3
Background Information
  • Uniprot Id

    Q9HCM3

  • Target Species

    Human

  • Target Name

    KIAA1549

  • Target Full Name

    UPF0606 protein KIAA1549

  • Target Function

    May play a role in photoreceptor function.

  • Target Involvement

    A chromosomal aberration involving KIAA1549 is found in pilocytic astrocytoma. A tandem duplication of 2 Mb at 7q34 leads to the expression of a KIAA1549-BRAF fusion protein with a constitutive kinase activity and inducing cell transformation.

  • Target Subcellular Location

    Membrane; Multi-pass membrane protein. Cell projection, cilium.

  • Target Protein Families

    UPF0606 family

  • Target Tissue Specificity

    [Isoform 1]: Expression is low to moderate in retina and tissues, such as heart and kidney, and is predominantly expressed in brain.; [Isoform 4]: Abundantly expressed in the retina, compared with only minimal expression in brain and other tissues.

  • Target Synonyms

    KIAA1549; UPF0606 protein KIAA1549

Inquire Recombinant Human UPF0606 protein KIAA1549 (KIAA1549), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification